MENU
TRVI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Trevi Therapeutics (TRVI) Ownership - Who owns Trevi Therapeutics?
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
195 Church Street
Phone
+1 203 304-2499
Employees
25
Web
https://www.trevitherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
586.86M
P/E Ratio
N/A
Total Cash
65.49M
Projected Growth
N/A
Total Debt
1.11M
Revenue
N/A
Risk (Beta)
0.65
Dividend Yield
N/A
Total Cash/Share
0.68
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TRVI
Capitalization
587M
P/E Ratio
N/A
Risk (Beta)
0.65
Dividend Yield
N/A
Total Cash
65.5M
Total Cash/Share
0.68
Total Debt
1.11M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
59M
P/B Ratio
6.08
Cash Flow
N/A
Earnings
-0.44
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
75K
Current Ratio
7.38
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-44.19M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-53.78
Shares Held By Institutions
337M
Shares Outstanding - Current
96.7M
Total Liabilities
9.94M
Total Volume MTD
N/A
Value
N/A
Gain YTD
52.184
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer and manufacturer of neurological products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
195 Church Street
Phone
+1 203 304-2499
Employees
25
Web
https://www.trevitherapeutics.com